AbbVie ABBV
NYSE ABBV
$265.38 +3.55 (+1.36%)
As of: Aug 21, 2026 · 10:17 AM EDT

AbbVie (ABBV) Net Margin (2012 - 2026)

AbbVie (ABBV) posted quarterly Net Margin of 4.65% for Q1 2026, down 501.0% year-over-year from 1.16% in Q1 2025, and down 57.46% quarter-over-quarter from 10.92% in Q4 2025.

AbbVie (ABBV) Net Margin (2012 - 2026) Analysis & Trends

AbbVie (ABBV) has reported Net Margin for 15 consecutive years, with 4.65% the latest figure, recorded in Q1 2026.

  • In Q1 2026, Net Margin fell 501.0% year-over-year to 4.65%; the TTM figure through Mar 2026 stood at 5.8% (down 153.0% YoY), while the FY2025 annual figure was 6.92%, down 69.0% from the prior year.
  • Net Margin retreated to 4.65% in Q1 2026 per ABBV's latest filing, from 10.92% in the prior quarter.
  • Across five years, Net Margin topped out at 33.19% in Q1 2022 and bottomed at 0.79% in Q1 2023.
  • Historically, Net Margin has averaged 10.52% across 5 years, with a median of 9.66% in 2025.
  • Annual changes were most pronounced in 2023 — Net Margin plunged 3398 bps — and 2024, when it surged 1194 bps.
  • AbbVie's Net Margin stood at 16.35% in 2022, then slumped by 65 bps to 5.76% in 2023, then plunged by 103 bps to 0.15% in 2024, then surged by 7271 bps to 10.92% in 2025, then slumped by 57 bps to 4.65% in 2026.
  • Business Quant data shows ABBV's Net Margin at 4.65% in Q1 2026, 10.92% in Q4 2025, and 1.19% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 652.45 Bn 631.70 Bn 17.26 Bn 21.86%
2 AbbVie 469.14 Bn 462.57 Bn 12.70 Bn 21.28%
3 Merck 381.04 Bn 373.90 Bn 12.21 Bn -8.05%
4 Novartis Ag 301.58 Bn 293.89 Bn 11.24 Bn 22.65%
5 Astrazeneca 257.69 Bn 252.79 Bn 12.86 Bn 16.30%
6 Amgen 236.91 Bn 222.92 Bn 7.24 Bn 23.62%
7 Gilead Sciences 182.62 Bn 179.44 Bn 6.22 Bn -134.51%
8 Pfizer 161.28 Bn 149.58 Bn 10.94 Bn -1.58%
9 Gsk 105.81 Bn 101.64 Bn 8.24 Bn 5.17%
10 Sanofi 54.98 Bn 47.60 Bn 10.79 Bn 2.96%

Historic Data

Download Data
DateValue
Jun 30, 2026 21.28%
Mar 31, 2026 4.65%
Dec 31, 2025 10.92%
Sep 30, 2025 1.19%
Jun 30, 2025 6.10%
Mar 31, 2025 9.66%
Dec 31, 2024 -0.15%
Sep 30, 2024 10.82%
Jun 30, 2024 9.49%
Mar 31, 2024 11.15%
Dec 31, 2023 5.76%
Sep 30, 2023 12.79%
Jun 30, 2023 14.62%
Mar 31, 2023 -0.79%
Dec 31, 2022 16.35%
Sep 30, 2022 26.68%
Jun 30, 2022 6.36%
Mar 31, 2022 33.19%
Dec 31, 2021 27.17%
Sep 30, 2021 22.17%